Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial.

Sabchareon, Arunee; Wallace, Derek; Sirivichayakul, Chukiat; Limkittikul, Kriengsak; Chanthavanich, Pornthep; Suvannadabba, Saravudh; Jiwariyavej, Vithaya; Dulyachai, Wut; Pengsaa, Krisana; Wartel, T Anh; Moureau, Annick; Saville, Melanie; Bouckenooghe, Alain; Viviani, Simonetta; Tornieporth, Nadia G; Lang, Jean

Sabchareon, Arunee; Wallace, Derek; Sirivichayakul, Chukiat; Limkittikul, Kriengsak; Chanthavanich, Pornthep; Suvannadabba, Saravudh; Jiwariyavej, Vithaya; Dulyachai, Wut; Pengsaa, Krisana; Wartel, T Anh; Moureau, Annick; Saville, Melanie; Bouckenooghe, Alain; Viviani, Simonetta; Tornieporth, Nadia G; Lang, Jean.

Affiliation

Sabchareon A; Department of Tropical Pediatrics, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.

Lancet ; 380(9853): 1559-67, 2012 Nov 03.

Article in En | MEDLINE | ID: mdl-22975340

Subject(s)

Dengue Vaccines/therapeutic use; Dengue/prevention & control; Child; Child, Preschool; Dengue Vaccines/immunology; Dengue Virus/immunology; Female; Humans; Male; Serotyping; Treatment Outcome; Vaccines, Attenuated; Vaccines, Synthetic

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dengue / Dengue Vaccines Type of study: Clinical_trials / Guideline Limits: Child / Child, preschool / Female / Humans / Male Language: En Journal: Lancet Year: 2012 Type: Article Affiliation country: Thailand

Fulltext

XML

PubMed Links

Search on Google